Key points:
- The U.S., the worst-hit country, has reached ten million, India, the second worst-hit country, has exceeded eight million.
- Brazil said it expected a vaccine to be accepted and available for use by June 2021.
- Antonio Barra Torres said that while Anvisa has not agreed on the minimum efficacy needed to authorize a vaccine.
- Russia, which claims to have produced the world’s first licensed Covid-19 vaccine.
- EU leaders decided on Thursday to ‘fairly administer’ a disease vaccine among the members of countries.
A worldwide search for a coronavirus (Covid-19) disease vaccine is ongoing, even though the worldwide count has risen to more than 45 million due to the outbreak, including 1.1 million fatalities.
Although the U.S., the worst-hit country, has reached ten million, India, the second worst-hit country, has exceeded eight million.
In the recent coronavirus vaccine report, Brazil said it expected a vaccine to be accepted and available for use by June 2021.
In its experiments, Russia briefly suspended the vaccination of new volunteers.
Here are the following details on the global hunt for a vaccine for Covid-19:
Brazil:
1.) Antonio Barra Torres, the president of the country’s health authority, Anvisa, said Brazil is expected to have a vaccine, approved and ready for use, by June 2021.
Torres said that while Anvisa has not agreed on the minimum efficacy needed to authorize a vaccine, vaccinations of less than 50 per cent efficacy have been licensed by the regulator in the past. Globally, Brazil has the third-highest number of incidents.
Russia:
2.) In its vaccine trial, Russia, which claims to have produced the world’s first licensed Covid-19 vaccine — the Sputnik V — has briefly paused vaccinating new recruits owing to heavy dosage demand in the middle of a shortage.
Some clinics in the Russian capital of Moscow announced that the first component of the two-dose jab had been expressly omitted (the second component was inserted 21 days after the first).
Nevertheless, the head of the Institute that developed the vaccine said the decision was “due to a new emphasis on providing a second dose to those already vaccinated.”
American:
3.) On Thursday, the American biotechnology company Moderna Inc said it is on schedule to announce early results from next month’s late-stage trial of its Covid-19 vaccine.
The organization is undertaking trials on 30,000 people, adding that it is planned that an independent data monitoring committee will conduct an ongoing review of its practices in November.
Moderna is designing a vaccine called mRNA and claims it plans 20 million doses to be manufactured by the end of 2021.
Europe:
4.) EU leaders decided on Thursday to ‘fairly administer’ a disease vaccine among member countries, if and where one becomes available. “Charles Michel, President from the European Council, said:”
We very much decided, repeatedly around the video conference table, to ensure an equal allocation between the Member States.
